Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be ...

As a psychiatrist, I have two options for treating my patients: mood stabilizers, which are usually anticonvulsants, and antipsychotics. Antipsychotics are a key treatment in managing bipolar I ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Bipolar disorder is a lifelong condition. It is not yet curable, but medication ... similar to seasonal affective depression. Transcranial magnetic stimulation is another option for depression.

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Even though currently there are treatments that have been studied and approved specifically for bipolar depression, antidepressants remain the most common treatment, despite of the fact that there ...

Fact checked by Nick Blackmer The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, ...

Minocycline, a drug perhaps better ... brain cause some cases of serious depression. (By the way, lithium, the “magic bullet” for so many people with bipolar disorder, also works through ...